Table 4 Equivalent dose contributions and effective doses (μSv) attained in the ankle region using MSCT, CBCT and radiography devices
Siemens | NewTom 5G | Shimadzu | ||||
|---|---|---|---|---|---|---|
Sensation | CBCT | Planmed | FH-21 HR | |||
Open | Hi Res | Standard | Standard | Verity | X-ray | |
MSCT | “12 × 8” | “15 × 12” | “18 × 16” | CBCT | AP+LAT | |
Bone marrow | 9.5 | 3.9 | 1.8 | 0.8 | 2.7 | 0.7 |
Bone surface | 7.2 | 7.3 | 1.2 | 0.6 | 1.9 | 0.3 |
Skin | 3.1 | 2.2 | 0.7 | 0.3 | 0.9 | 0.3 |
Remainder | ||||||
Lymphatic nodes | 0.9 | 0.8 | 0.2 | 0.1 | 0.3 | 0.1 |
Muscles | 0.6 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Effective dose | 21.4 | 14.3 | 4.0 | 1.9 | 6.0 | 1.5 |